Wednesday, June 10, 2026

pharma Β· Patency of the Ductus Arteriosus Β· Atopic Dermatitis Β· CNTB

S.L

S.L clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

SAN DIEGO, CA, EU HQ
Public company Type
CNTB Β· NYSE Ticker
Company details
Status
Public
HQ
SAN DIEGO, CA, EU
Programs
15
Drugs
11
Patents
179
Intelligence Β· Clinical Programs

S.L projects

2 ClinicalTrials.gov programs sponsored by S.L.

S.L has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Acetaminophen

    S.L

    Patency of the Ductus Arteriosus

    phase 3 small molecule completed

    1 trial
  2. CBP-201

    S.L

    Atopic Dermatitis

    phase 3 small molecule active

    2 trials

Frequently asked questions

How many clinical projects does S.L have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.